BIIB - Biogen Inc

Healthcare - Sector
Coverage

BIIB is currently covered by 33 analysts with average potential upside of $51.1 (19.04%) backed by 666 price targets and 828 ratings. Analyst's average stock valuation to be materialised ratio is 74.3% with an average time for price targets to be met of 275.18 days.

Most recent stock forecast was given by MATTHEW HARRISON from MORGAN STANLEY on 24-Jan-2023.

Highest price target for BIIB is 415, Lowest price target is 197, average price target is 306.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

345

$56.72 (19.68%)

325

14 days ago

36/53 (67.92%)

$72.73 (26.43%)

327

Hold

295

$6.72 (2.33%)

220

2 months 6 days ago

2/4 (50%)

$-13.69 (-5.61%)

337

Buy

350

$61.72 (21.41%)

325

2 months 8 days ago

21/41 (51.22%)

$80.14 (30.04%)

298

Hold

313

$24.72 (8.57%)

275

2 months 8 days ago

19/20 (95%)

$16.95 (5.85%)

230

Hold

247

$-41.28 (-14.32%)

217

2 months 8 days ago

15/19 (78.95%)

$-27.41 (-9.67%)

142

Show more analysts